ImmunoPrecise Antibodies Ltd (IPA)
1.18
+0.06
(+5.36%)
USD |
NASDAQ |
May 17, 16:00
1.19
+0.01
(+0.85%)
After-Hours: 20:00
ImmunoPrecise Antibodies Gross Profit Margin (Quarterly): 51.39% for Jan. 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 51.39% |
October 31, 2023 | 48.03% |
July 31, 2023 | 49.14% |
April 30, 2023 | 59.44% |
January 31, 2023 | 57.32% |
October 31, 2022 | 53.61% |
July 31, 2022 | 52.87% |
April 30, 2022 | 63.29% |
January 31, 2022 | 53.71% |
October 31, 2021 | 54.53% |
July 31, 2021 | 54.62% |
April 30, 2021 | 56.94% |
January 31, 2021 | 78.89% |
October 31, 2020 | 58.65% |
July 31, 2020 | 64.01% |
Date | Value |
---|---|
April 30, 2020 | 46.90% |
January 31, 2020 | 55.12% |
October 31, 2019 | 78.74% |
July 31, 2019 | 50.68% |
April 30, 2019 | 21.62% |
January 31, 2019 | 58.17% |
October 31, 2018 | 51.59% |
July 31, 2018 | 54.58% |
April 30, 2018 | 40.64% |
January 31, 2018 | 57.40% |
October 31, 2017 | 40.51% |
July 31, 2017 | 7.89% |
April 30, 2017 | 93.34% |
January 31, 2017 | 24.43% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
46.90%
Minimum
Apr 2020
78.89%
Maximum
Jan 2021
57.26%
Average
54.62%
Median
Jul 2021
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -25.96% |
Return on Assets | -18.22% |
Return on Invested Capital | -25.96% |
Profit Margin (Quarterly) | -47.26% |
Operating Margin (Quarterly) | -53.69% |
Return on Net Operating Assets | -18.25% |